• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Cutera Inc.

    3/5/25 5:17:11 PM ET
    $CUTR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $CUTR alert in real time by email
    S-8 POS 1 cutr-sx8posams.htm S-8 POS Document

    As filed with the Securities and Exchange Commission on March 5, 2025
    Registration No. 333-114149
    Registration No. 333-123495
    Registration No. 333-132583
    Registration No. 333-141376
    Registration No. 333-149703
    Registration No. 333-158160
    Registration No. 333-187502
    Registration No. 333-206864
    Registration No. 333-221542
    Registration No. 333-258283
    Registration No. 333-271214
    Registration No. 333-273924
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333- 114149 
    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333- 123495 
    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333- 132583 
    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333- 141376 
    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333- 149703 
    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333- 158160 
    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333- 187502 
    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333- 206864 
    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333- 221542 
    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333- 258283 
    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333- 271214 
    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333- 273924 
    UNDER THE SECURITIES ACT OF 1933
     
    CUTERA, INC.
    (Exact name of registrant as specified in its charter)
     
    Delaware 77-0492262
    (State or other jurisdiction of
    incorporation or organization)
     
    (I.R.S. Employer
    Identification No.)
    3240 Bayshore Blvd.
    Brisbane, California 94005
    (Address of principal executive offices, including zip code)

    1998 Stock Plan



    2004 Equity Incentive Plan
    2004 Employee Stock Purchase Plan
    2019 Equity Incentive Plan
    2023 Inducement Equity Incentive Plan
    (Full title of the plans)

    Taylor Harris
    Chief Executive Officer
    Cutera, Inc.
    3240 Bayshore Blvd.
    Brisbane, California 94005
    (415) 657-5500
    (Name, address, including zip code, and telephone number, including area code, of agent for service)
     
    With copies to:

    Marianne Sarrazin
    Goodwin Procter LLP
    525 Market Street, 32nd Floor
    San Francisco, CA 94105
    (415) 733-6000
     
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated filer ☐ Accelerated filer ☐
    Non-accelerated filer ☒ Smaller reporting company ☐
      Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
     
     



    DEREGISTRATION OF SECURITIES
    This Post-Effective Amendment relates to the following Registration Statements of Cutera, Inc., a Delaware corporation (the “Registrant”), on Form S-8 (collectively, the “Registration Statements”), which have been previously filed with the Securities and Exchange Commission (the “SEC”), to deregister any and all shares of the Registrant’s common stock, par value $0.001 per share (the “Registrant’s Common Stock”), registered but unsold or otherwise unissued under each such Registration Statement as of the date hereof:
     
    • Registration Statement No. 333-114149, filed with the SEC on April 2, 2004, registering a total of 3,833,917 shares of the Registrant’s Common Stock issuable upon exercise of then presently outstanding options issued under the Registrant’s 1998 Stock Plan, a total of 1,889,404 shares of the Registrant’s Common Stock issuable upon exercise of options that had not yet been granted under the Registrant’s 1998 Stock Plan and shares to be granted under the Registrant’s 2004 Equity Incentive Plan, and a total of 200,000 shares of the Registrant’s Common Stock under the Registrant’s 2004 Employee Stock Purchase Plan;

    • Registration Statement No. 333-123495, filed with the SEC on March 22, 2005, registering a total of 547,860 shares of the Registrant’s Common Stock under the Registrant’s 2004 Equity Incentive Plan and a total of 219,144 shares of the Registrant’s Common Stock under the Registrant’s 2004 Employee Stock Purchase Plan;

    • Registration Statement No. 333-132583, filed with the SEC on March 20, 2006, registering a total of 610,674 shares of the Registrant’s Common Stock under the Registrant’s 2004 Equity Incentive Plan and a total of 244,269 shares of the Registrant’s Common Stock under the Registrant’s 2004 Employee Stock Purchase Plan;

    • Registration Statement No. 333-141376, filed with the SEC on March 16, 2007, registering a total of 646,969 shares of the Registrant’s Common Stock under the Registrant’s 2004 Equity Incentive Plan and a total of 258,788 shares of the Registrant’s Common Stock under the Registrant’s 2004 Employee Stock Purchase Plan;

    • Registration Statement No. 333-149703, filed with the SEC on March 13, 2008, registering a total of 636,922 shares of the Registrant’s Common Stock under the Registrant’s 2004 Equity Incentive Plan and a total of 254,769 shares of the Registrant’s Common Stock under the Registrant’s 2004 Employee Stock Purchase Plan;

    • Registration Statement No. 333-158160, filed with the SEC on March 24, 2009, registering a total of 256,121 shares of the Registrant’s Common Stock under the Registrant’s 2004 Employee Stock Purchase Plan;

    • Registration Statement No. 333-187502, filed with the SEC on March 25, 2013, registering a total of 1,910,000 shares of the Registrant’s Common Stock under the Registrant’s 2004 Equity Incentive Plan;

    • Registration Statement No. 333-206864, filed with the SEC on September 10, 2015, registering a total of 1,500,000 shares of the Registrant’s Common Stock under the Registrant’s 2004 Equity Incentive Plan;

    • Registration Statement No. 333-221542, filed with the SEC on November 14, 2017, registering a total of 1,600,000 shares of the Registrant’s Common Stock under the Registrant’s Amended and Restated 2004 Equity Incentive Plan;

    • Registration Statement No. 333-258283, filed with the SEC on July 30, 2021, registering a total of 1,750,000 shares of the Registrant’s Common Stock under the Registrant’s Amended and Restated 2019 Equity Incentive Plan;

    • Registration Statement No. 333-271214, filed with the SEC on April 11, 2023, registering a total of 600,000 shares of the Registrant’s Common Stock under the Registrant’s Amended and Restated 2019 Equity Incentive Plan; and

    • Registration Statement No. 333- 273924, filed with the SEC on August 11, 2023, registering a total of 1,300,000 shares of the Registrant’s Common Stock under the Registrant’s Amended and Restated 2019 Equity Incentive Plan and a total of 2,500,000 shares of the Registrant’s Common Stock under the Registrant’s 2023 Inducement Equity Incentive Plan.
     

     

     

     




    As previously disclosed, on March 5, 2025, the Registrant and certain of its subsidiaries commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas. In connection with the foregoing, the offerings pursuant to the Registration Statements are being terminated.
    In accordance with an undertaking made by the Registrant in each of the Registration Statements to remove from registration, by means of a post-effective amendment, any of the securities that remain unsold at the termination of the offering, the Registrant hereby removes from registration all securities that were registered but unsold or otherwise unissued under each of the Registration Statements as of the date hereof.




    SIGNATURES
    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the Brisbane, State of California, on this 5th day of March, 2025.
     
    CUTERA, INC.


    By:    /s/ Stuart Drummond    
    Name:     Stuart Drummond
    Title:    Interim Chief Financial Officer

    No other person is required to sign this Post-Effective Amendment in reliance upon Rule 478 under the Securities Act of 1933, as amended.

    Get the next $CUTR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CUTR

    DatePrice TargetRatingAnalyst
    3/22/2024Underperform → Mkt Perform
    William Blair
    7/27/2023$14.00 → $18.00Underweight → Neutral
    Piper Sandler
    5/11/2023Outperform → Mkt Perform
    William Blair
    5/10/2023$14.00Underweight
    Piper Sandler
    3/30/2023Buy → Hold
    Maxim Group
    1/31/2023Mkt Perform
    William Blair
    1/11/2023$85.00 → $33.00Overweight → Neutral
    Cantor Fitzgerald
    12/28/2022$78.00 → $68.00Overweight
    Stephens
    More analyst ratings

    $CUTR
    SEC Filings

    See more
    • SEC Form EFFECT filed by Cutera Inc.

      EFFECT - CUTERA INC (0001162461) (Filer)

      3/26/25 12:15:06 AM ET
      $CUTR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form POS AM filed by Cutera Inc.

      POS AM - CUTERA INC (0001162461) (Filer)

      3/25/25 6:30:00 AM ET
      $CUTR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 25 filed by Cutera Inc.

      25 - CUTERA INC (0001162461) (Filer)

      3/20/25 12:48:01 PM ET
      $CUTR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care